A Trial of Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection (AMR)

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: a91d7ab61c335dc837cc2ca4dcee2f6126ab16e3
First added on: Jan 17, 2026